Endoplasmic Reticulum Stress: A New Research Direction for Polycystic Ovary Syndrome?

DNA Cell Biol. 2022 Apr;41(4):356-367. doi: 10.1089/dna.2021.1050. Epub 2022 Mar 29.

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common gynecological endocrine disorders, with sporadic ovulation, excessive androgens, and polycystic ovarian changes as the main clinical manifestations. Due to the high heterogeneity of its clinical manifestations, the discussion on its pathogenesis has not been unified. Current research has found that genetic factors, hyperandrogenism, chronic inflammation and oxidative stress, insulin resistance, and obesity are strongly associated with PCOS. Recently, when studying the specific mechanisms of the abovementioned factors in PCOS, the biological response process of endoplasmic reticulum stress (ERS) has gradually come to researchers' attention, and several studies have confirmed the involvement of ERS in the pathogenesis of PCOS and the improvement of a series of pathological manifestations of PCOS after the application of ERS inhibitors, which may be a new entry point for the treatment of PCOS. In this article, we review the relationship between ERS and various pathogenic factors of PCOS.

Keywords: aromatic hydrocarbon receptor; endoplasmic reticulum stress; hyperandrogenism; inflammation and oxidative stress; insulin resistance; ovarian fibrosis; polycystic ovary syndrome.

Publication types

  • Review

MeSH terms

  • Endoplasmic Reticulum Stress
  • Female
  • Humans
  • Hyperandrogenism*
  • Insulin Resistance* / genetics
  • Male
  • Polycystic Ovary Syndrome* / genetics